000963 華東醫藥
按盤價 
39.370 -0.670 (-1.673%)
39.370 -0.670 (-1.673%) | 2025/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 32,664,143 | 3.77% | 41,905,707 | 40,623,783 | 37,714,587 | 34,563,301 | |
| 減：營業總成本 | 29,289,598 | 3.54% | 37,493,020 | 37,081,915 | 34,568,570 | 31,727,336 | |
| 其中:營業成本 | 21,715,689 | 2.28% | 27,988,547 | 27,461,732 | 25,682,497 | 23,957,371 | |
| 財務費用 | 11,328 | -70.20% | 22,265 | 51,190 | 78,257 | 22,075 | |
| 資產減值損失 | -- | -- | (41,006) | (6,520) | (3,822) | (16,908) | |
| 公允價值變動收益 | -- | -- | -- | (13,756) | 28,469 | -- | |
| 投資收益 | (119,368) | 37.66% | (129,191) | (219,713) | (141,560) | (96,312) | |
| 其中：對聯營企業和合營企業的投資收益 | (75,251) | 37.92% | (68,453) | (188,391) | (115,619) | (53,433) | |
| 營業利潤 | 3,350,590 | 4.21% | 4,324,737 | 3,452,927 | 3,061,454 | 2,855,714 | |
| 利潤總額 | 3,262,622 | 4.11% | 4,301,514 | 3,465,986 | 3,031,124 | 2,827,535 | |
| 減：所得稅費用 | 520,763 | -8.84% | 807,328 | 619,589 | 498,499 | 488,907 | |
| 淨利潤 | 2,741,858 | 6.99% | 3,494,186 | 2,846,397 | 2,532,626 | 2,338,628 | |
| 減：非控股權益 | (6,058) | -2,282.43% | (17,919) | 7,536 | 33,411 | 36,996 | |
| 股東淨利潤 | 2,747,916 | 7.24% | 3,512,105 | 2,838,861 | 2,499,214 | 2,301,631 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 1.568 | 7.09% | 2.005 | 1.622 | 1.428 | 1.315 | |
| 每股派息 (元) * | 0.350 | 0.00% | 0.930 | 0.580 | 0.290 | 0.290 | |
| 每股淨資產 (元) * | 13.759 | 9.50% | 13.145 | 11.997 | 10.592 | 9.475 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 16/12/2025 15:54 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
